These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37371780)

  • 1. UBL3 Interacts with Alpha-Synuclein in Cells and the Interaction Is Downregulated by the EGFR Pathway Inhibitor Osimertinib.
    Chen B; Hasan MM; Zhang H; Zhai Q; Waliullah ASM; Ping Y; Zhang C; Oyama S; Mimi MA; Tomochika Y; Nagashima Y; Nakamura T; Kahyo T; Ogawa K; Kaneda D; Yoshida M; Setou M
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-Synuclein Interaction with UBL3 Is Upregulated by Microsomal Glutathione S-Transferase 3, Leading to Increased Extracellular Transport of the Alpha-Synuclein under Oxidative Stress.
    Yan J; Kahyo T; Zhang H; Ping Y; Zhang C; Jiang S; Ji Q; Ferdous R; Islam MS; Oyama S; Aramaki S; Sato T; Mimi MA; Hasan MM; Setou M
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBL3 Interaction with α-Synuclein Is Downregulated by Silencing MGST3.
    Yan J; Zhang H; Tomochika Y; Chen B; Ping Y; Islam MS; Aramaki S; Sato T; Nagashima Y; Nakamura T; Kahyo T; Kaneda D; Ogawa K; Yoshida M; Setou M
    Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBL3 modification influences protein sorting to small extracellular vesicles.
    Ageta H; Ageta-Ishihara N; Hitachi K; Karayel O; Onouchi T; Yamaguchi H; Kahyo T; Hatanaka K; Ikegami K; Yoshioka Y; Nakamura K; Kosaka N; Nakatani M; Uezumi A; Ide T; Tsutsumi Y; Sugimura H; Kinoshita M; Ochiya T; Mann M; Setou M; Tsuchida K
    Nat Commun; 2018 Sep; 9(1):3936. PubMed ID: 30258067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-like 3 as a new protein-sorting factor for small extracellular vesicles.
    Takanashi Y; Kahyo T; Kamamoto S; Zhang H; Chen B; Ping Y; Mizuno K; Kawase A; Koizumi K; Satou M; Funai K; Shiiya N; Setou M
    Cell Struct Funct; 2022; 47(1):1-18. PubMed ID: 35197392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive identification of ubiquitin-like 3 (UBL3)-interacting proteins in the mouse brain.
    Ageta H; Nishioka T; Yamaguchi H; Tsuchida K; Ageta-Ishihara N
    Mol Brain; 2024 Aug; 17(1):57. PubMed ID: 39148092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Potential Therapeutic Target for Cancer in Ubiquitin-Like Proteins-UBL3.
    Zhang H; Chen B; Waliullah ASM; Aramaki S; Ping Y; Takanashi Y; Zhang C; Zhai Q; Yan J; Oyama S; Kahyo T; Setou M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs.
    Ageta H; Tsuchida K
    Cell Mol Life Sci; 2019 Dec; 76(24):4829-4848. PubMed ID: 31363817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDE6D Mediates Trafficking of Prenylated Proteins NIM1K and UBL3 to Primary Cilia.
    Faber S; Letteboer SJF; Junger K; Butcher R; Tammana TVS; van Beersum SEC; Ueffing M; Collin RWJ; Liu Q; Boldt K; Roepman R
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies.
    Fayyad M; Majbour NK; Vaikath NN; Erskine D; El-Tarawneh H; Sudhakaran IP; Abdesselem H; El-Agnaf OMA
    Neurosci Lett; 2020 Apr; 725():134899. PubMed ID: 32156613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.
    Kim C; Kwon S; Iba M; Spencer B; Rockenstein E; Mante M; Adame A; Shin SJ; Fields JA; Rissman RA; Lee SJ; Masliah E
    Exp Mol Med; 2021 Feb; 53(2):281-290. PubMed ID: 33594256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology.
    Longhena F; Faustini G; Spillantini MG; Bellucci A
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-translational modification of lysine residues in erythrocyte α-synuclein.
    Amagai R; Yoshioka S; Otomo R; Nagano H; Hashimoto N; Sakakibara R; Tanaka T; Okado-Matsumoto A
    J Biochem; 2023 Mar; 173(3):177-184. PubMed ID: 36469357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-like protein 3 (UBL3) is required for MARCH ubiquitination of major histocompatibility complex class II and CD86.
    Liu H; Wilson KR; Firth AM; Macri C; Schriek P; Blum AB; Villar J; Wormald S; Shambrook M; Xu B; Lim HJ; McWilliam HEG; Hill AF; Edgington-Mitchell LE; Caminschi I; Lahoud MH; Segura E; Herold MJ; Villadangos JA; Mintern JD
    Nat Commun; 2022 Apr; 13(1):1934. PubMed ID: 35411049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The good and bad of therapeutic strategies that directly target α-synuclein.
    Longhena F; Faustini G; Brembati V; Pizzi M; Bellucci A
    IUBMB Life; 2020 Apr; 72(4):590-600. PubMed ID: 31693290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser
    Dutta S; Hornung S; Taha HB; Biggs K; Siddique I; Chamoun LM; Shahpasand-Kroner H; Lantz C; Herrera-Vaquero M; Stefanova N; Loo JA; Bitan G
    ACS Chem Neurosci; 2023 Apr; 14(7):1238-1248. PubMed ID: 36920792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies.
    Sandoval IM; Marmion DJ; Meyers KT; Manfredsson FP
    J Parkinsons Dis; 2021; 11(s2):S189-S197. PubMed ID: 34092656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies.
    Karpowicz RJ; Haney CM; Mihaila TS; Sandler RM; Petersson EJ; Lee VM
    J Biol Chem; 2017 Aug; 292(32):13482-13497. PubMed ID: 28611062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamatergic transmission and receptor expression in the synucleinopathy h-α-synL62 mouse model: Effects of hydromethylthionine.
    Schwab K; Chasapopoulou Z; Frahm S; Magbagbeolu M; Cranston A; Harrington CR; Wischik CM; Theuring F; Riedel G
    Cell Signal; 2022 Sep; 97():110386. PubMed ID: 35709886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a potential tumor suppressor gene,
    Zhao X; Yongchun Z; Qian H; Sanhui G; Jie L; Hong Y; Yanfei Z; Guizhen W; Yunchao H; Guangbiao Z
    Cancer Biol Med; 2020 Feb; 17(1):76-87. PubMed ID: 32296577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.